Related Experiment Video
Updated: Jul 18, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Vascular cognitive impairment - Past, present, and future challenges
Atef Badji1, Jessica Youwakim2, Alexandra Cooper3
1Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden.
Insights
Vascular cognitive impairment (VCI) arises from cerebrovascular lesions. Understanding the interplay between risk factors and brain changes is crucial for developing effective VCI treatments.
Area of Science:
- Neuroscience
- Gerontology
- Cardiovascular Medicine
Background:
- Vascular cognitive impairment (VCI) is a spectrum of cognitive disorders caused by cerebrovascular lesions.
- Genetic and environmental risk factors synergistically interact, leading to brain changes and VCI.
- Pathological processes and temporal dynamics underlying VCI remain poorly understood.
Purpose of the Study:
- To summarize the evidence linking vascular risk factors to cognitive dysfunction.
- To explore potential structural and biochemical pathophysiological processes in VCI.
- To identify challenges and future research directions for VCI.
Main Methods:
- Narrative review of existing literature.
- Evidence-based summary of VCI mechanisms.
- Discussion of research challenges and future directions.
Main Results:
- Vascular risk factors and disorders are linked to cognitive dysfunction.
- Cerebrovascular lesions contribute to VCI.
- Multidimensional data integration is needed to understand VCI pathophysiology.
Conclusions:
- Future research should focus on comorbid vascular burden and integrate biomarkers.
- A life-course approach and consideration of sex/gender differences are essential.
- Leveraging multidimensional data will advance VCI understanding.
Abstract:
Vascular cognitive impairment (VCI) is a lifelong process encompassing a broad spectrum of cognitive disorders, ranging from subtle or mild deficits to prodromal and fully developed dementia, originating from cerebrovascular lesions such as large and small vessel disease. Genetic predisposition and environmental exposure to risk factors such as unhealthy lifestyles, hypertension, cardiovascular disease, and metabolic disorders will synergistically interact, yielding biochemical and structural brain changes, ultimately culminating in VCI. However, little is known about the pathological processes underlying VCI and the temporal dynamics between risk factors and disease mechanisms (biochemical and structural brain changes). This narrative review aims to provide an evidence-based summary of the link between individual vascular risk/disorders and cognitive dysfunction and the potential structural and biochemical pathophysiological processes. We also discuss some key challenges for future research on VCI. There is a need to shift from individual risk factors/disorders to comorbid vascular burden, identifying and integrating imaging and fluid biomarkers, implementing a life-course approach, considering possible neuroprotective influences of positive life exposures, and addressing biological sex at birth and gender differences. Finally, this review highlights the need for future researchers to leverage and integrate multidimensional data to advance our understanding of the mechanisms and pathophysiology of VCI.
Related Concept Videos
Cognitive Development During Adulthood
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Language and Cognition

